Ectopic deposition of melanin pigments as detoxifying mechanism: A paradigm for basal nuclei pigmentation

Biochemical and Biophysical Research Communications

Volumn 314, Issue 2, 2004, Pages 631-637

  De Marco, Federico ^a   Foppoli, Cesira ^b   Coccia, Raffaella ^c   Blarzino, Carla ^c   Perluigi, Marzia ^c   Cini, Chiara ^c   Marcante, Maria Luisa ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Human keratinocytes; Melanin; Neuromelanin; Parkinson's disease; Peroxidase; Tetrahydropapaveroline

Indexed keywords

CATECHOLAMINE; NEUROMELANIN; NEUROTRANSMITTER; PEROXIDASE; QUINONE DERIVATIVE; SEMIQUINONE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRAIN; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DETOXIFICATION; DIPLOIDY; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOGENESIS; NERVE DEGENERATION; NEUROPROTECTION; OLIVARY NUCLEUS; PARKINSON DISEASE; PIGMENTATION; PRIORITY JOURNAL;

EID: 0345743588     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.127     Document Type: Article

References (40)

1. Odh G., Carstam R., Paulson J., Wittbjer A., Rosengren E., Rorsman H. Neuromelanin of the human substantia nigra: a mixed-type melanin. J. Neurochem. 62:1994;2030-2036.
2. Double K.L., Zecca L., Costi P., Mauer M., Griesinger C., Ito S., Ben-Shachar D., Bringmann G., Fariello R.G., Riederer P., Gerlach M. Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins. J. Neurochem. 75:2000;2583-2589.
3. Carlsson A., Fornstedt B. Possible mechanisms underlying the special vulnerability of dopaminergic neurons. Acta Neurol. Scand. Suppl. 136:1991;16-18.
4. Offen D., Ziv I., Barzilai A., Gorodin S., Glater E., Hochman A., Melamed E. Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease. Neurochem. Int. 31:1997;207-216.
5. Youdim M.B., Ben-Shachar D., Riederer P. The enigma of neuromelanin in Parkinson's disease substantia nigra. J. Neural Transm. Suppl. 43:1994;113-122.
6. Nagatsu T. Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci. Res. 29:1997;99-111.
7. ′ -dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines Neurosci. Lett. 291:2000;89-92.
8. Deitrich R., Erwin V. Biogenic amine-aldehyde condensation products: tetrahydroisoquinolines and tryptolines (beta-carbolines). Annu. Rev. Pharmacol. Toxicol. 20:1980;55-80.
9. McNaught K.S., Carrupt P.A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P., Marsden C.D. Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem. Pharmacol. 56:1998;921-933.
10. G. Prota, in: Melanins and Melanogenesis, Harcourt Brace Jovanovich Publishers, San Diego, Academic Press, Inc., 1992.
11. Carstam R., Brinck C., Hindemith-Augustsson A., Rorsman H., Rosengren E. The neuromelanin of the human substantia nigra. Biochim. Biophys. Acta. 1097:1991;152-160.
12. 2 system. Int. J. Biochem. Cell Biol. 30:1998;457-463.
13. Foppoli C., Coccia R., Cini C., Rosei M.A. Catecholamines oxidation by xantine oxidase. Biochim. Biophys. Acta. 1334:1997;200-206.
14. 2-catalyzed oxidation of dihydroxyindoles: synthesis of melanin pigments and study on their antioxidant properties. Free Radic. Biol. Med. 26:1999;446-451.
15. Rosei M.A., Mosca L., Coccia R., Blarzino C., Musci G., De Marco C. Some biochemical properties of melanins from opioid peptides. Biochim. Biophys. Acta. 1199:1994;123-129.
16. Rosei M.A., Mosca L. Production of melanin pigments by chemical and enzymatic oxidation of tetrahydroisoquinolines. Biochem. Mol. Biol. Int. 35:1995;1253-1259.
17. Mosca L., Blarzino C., Coccia R., Foppoli C., Rosei M.A. Melanins from tetrahydroisoquinolines. Spectroscopic characteristics, scavenging activity and redox transfer properties. Free Radic. Biol. Med. 24:1998;161-167.
18. De Marco F., Perluigi M., Marcante M.L., Coccia R., Foppoli C., Blarzino C., Rosei M.A. Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells. Biochem. Pharmacol. 64:2002;1503-1512.
19. Perluigi M., De Marco F., Foppoli C., Coccia R., Blarzino C., Marcante M.L., Cini C. Tyrosinase protects human melanocytes from ROS-generating compounds. Biochem. Biophys. Res. Commun. 305:2003;250-256.
20. Pirisi L., Yasumoto S., Feller M., Doniger J., Di Paolo J.A. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol. 61:1987;1061-1066.
21. Dürst M., Dzarlieva-Petrusevska R.T., Boukamp P., Fusenig N.E., Gissmann L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene. 1:1987;251-256.
22. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:1988;761-771.
23. Gerlier N., Thomasset D. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods. 94:1986;5763-5769.
24. Bouvier M.M., Mytilineou C. Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro. J. Neurosci. 15:1995;7141-7149.
25. Ancans J., Thody A.J. Activation of melanogenesis by vacuolar type H+-ATPase inhibitors in amelanotic, tyrosinase positive human and mouse melanoma cells. FEBS Lett. 478:2000;57-60.
26. Everse J., Johnson M.C., Marini M.A. Peroxidative activities of hemoglobin and hemoglobin derivatives. Methods Enzymol. 231:1994;547-561.
27. Ernster L. DT-Diaphorase. Eastbrook R.W., Pullman M.E. Methods in Enzymology. vol. 10:1967;309-317 Academic Press, New York.
28. Spitz D.R., Oberley L.W. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal. Biochem. 179:1989;8-18.
29. Ursini F., Maiorino M., Brigelius-Flohe R., Aumann K.D., Roveri A., Schomburg D., Flohe L. Diversity of glutathione peroxidases. Methods Enzymol. 252:1995;38-53.
30. Kollias N., Sayre R.M., Zeise L., Chedekel M.R. Photoprotection by melanin. J. Photochem. Photobiol. B. 9:1991;135-160.
31. Sarna T. Properties and function of the ocular melanin - a photobiophysical view. J. Photochem. Photobiol. B. 12:1992;215-258.
32. Enochs W.S., Sarna T., Zecca L., Riley P.A., Swartz H.M. The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis. J. Neural Transm. Park. Dis. Dement. Sect. 7:1994;83-100.
33. Ikemoto K., Nagatsu I., Ito S., King R.A., Nishimura A., Nagatsu T. Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra? Neurosci. Lett. 253:1998;198-200.
34. d'Ischia M., Napolitano A., Prota G. Peroxidase as an alternative to tyrosinase in the oxidative polymerization of 5,6-dihydroxyindoles to melanin(s). Biochim. Biophys. Acta. 1073:1991;423-430.
35. Okun M.R. The role of peroxidase in mammalian melanogenesis: a review. Physiol. Chem. Phys. Med. NMR. 28:1996;91-100.
36. Riley P.A. Melanin. Int. J. Biochem. Cell Biol. 29:1997;1235-1239.
37. Sulzer D., Bogulavsky J., Larsen K.E., Behr G., Karatekin E., Kleinman M.H., Turro N., Krantz D., Edwards R.H., Greene L.A., Zecca L. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc. Natl. Acad. Sci. USA. 97:2000;11869-11874.
38. Sulzer D., Zecca L. Intraneuronal dopamine-quinone synthesis: a review. Neurotox. Res. 1:2000;181-195.
39. Zecca L., Zucca F.A., Wilms H., Sulzer D. Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci. 26:2003;578-580.
40. Zecca L., Fariello R., Riederer P., Sulzer D., Gatti A., Tampellini D. The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett. 510:2002;216-220.